Antibiotics, Vaccinations, and Anti-Inflammatory Medication Linked to Reduced Risk of Dementia
University of Cambridge
The study identified several drugs already licensed and in use that have the potential to be repurposed to treat dementia.
Dementia
Increasing Risk of Dementia in the US, Researchers Warn
Springer Nature
Study suggests the number of US adults who will probably develop dementia each year will increase from around 514,000 in 2020 to approximately 1 million in 2060
5 Clinical Laboratories Leading the Way in Patient Care
Michael Schubert, PhD
Trailblazing labs are among the first to adopt new tests and treatments for longstanding challenges
Mount Sinai Health System Among First to Use Blood Tests for Early Alzheimer’s Detection
Mount Sinai School of Medicine, Mount Sinai Hospital
Mount Sinai Health System among the first in the world to use blood tests as an early detection tool for Alzheimer’s disease and related dementias in patients
De novo Proteins in CSF Act as Brain Disorders Biomarkers
National Institutes of Health
Identifying and quantifying cryptic protein aggregates may help diagnose and develop therapies for brain disorders
The COMCID Study Raises New Questions in Dementia Research
National Cerebral and Cardiovascular Center
The COMCID study is Japan’s first multicenter investigator-initiated clinical trial involving patients with mild cognitive impairment
FDA Approves First Drug to Treat Dementia-Associated Agitation in AD Patients
U.S. Food and Drug Administration
Individuals who received two mg or three mg of Rexulti showed statistically significant and clinically meaningful improvements
Structural Variants Contributing to Non-Alzheimer’s Dementia Identified
National Institutes of Health
Discovery provides potential clues for Lewy body and frontotemporal dementias
New Blood-Based Biomarker to Diagnose Vascular Dementia
UCLA Health
Angiogenic biomarkers could allow clinicians to distinguish Alzheimer's-predominant dementia from significant vascular contribution
Diagnostic Marker Found for Deadly Brain Disease
Washington University School of Medicine
Discovery could accelerate progress toward therapies for primary tauopathies